source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Kangstem Biotech selects MaSTherCell for GMP manufacturing of atopic dermatitis cell therapy in Europe

Kangstem Biotech logo 3.11.18MaSTherCell logo 14.3.18Kangstem Biotech, a South Korean biotechnology company specialising in developing cell therapies using mesenchymal stem cells derived from human umbilical cord blood, has chosen Belgium-based MaSTherCell as its contract manufacturing partner for its European clinical trial of its Furestem-AD atopic dermatitis cell therapy. Kangstem is moving the therapy into late-phase clinical trials in South Korea and is now taking the opportunity to enter into Europe with its innovative cell therapy products. The partnership provides Kangstem access to MaSTherCell’s cell therapy manufacturing expertise, capabilities and new commercial facility, while MaSTherCell’s global facilities will allow Kangstem to further expand its activities into other continents.

For further information about KangStem Biotech visit www.kangstem.com and for further information about MaSTherCell visit www.masthercell.com

Last modified onWednesday, 07 November 2018 09:43